{{Drugbox
| IUPAC_name               = 11-ethoxy-5-methyl-5,11-dihydro-6''H''-dibenzo[b,e]azepin-6-one
| image                    = Etazepine.svg
| CAS_number               = 88124-27-0
| ATC_prefix               = None
| ATC_suffix               = 
| UNII = SBC76K7XWC
| PubChem                  = 65662
| ChEMBL = 2106559
| ChemSpiderID             = 59097
| C = 17 | H = 17 | N = 1 | O = 2
| molecular_weight         = 267.322 g/mol
| smiles                   = O=C3c1c(cccc1)C(OCC)c2c(cccc2)N3C
| StdInChI                 = 1S/C17H17NO2/c1-3-20-16-12-8-4-5-9-13(12)17(19)18(2)15-11-7-6-10-14(15)16/h4-11,16H,3H2,1-2H3
| StdInChIKey              = BLGFGFHRMMDRPC-UHFFFAOYSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = 
| routes_of_administration = 
}}

'''Etazepine''' ([[International Nonproprietary Name|INN]]) is an [[anticonvulsant]] with a [[tricyclic]] structure which is related to the [[benzodiazepine]]s, but was never marketed.<ref name="pmid2787643">{{cite journal |vauthors=Borsini F, Volterra G, Cutrufo C, Furio M, Meli A | title = Pharmacological profile of the new anticonvulsant etazepine | journal = Arzneimittel-Forschung | volume = 39 | issue = 4 | pages = 475â€“9 |date=April 1989 | pmid = 2787643 | doi = | url = }}</ref> It appears to exert its effects via acting through the [[GABAergic]] system.<ref name="pmid2787643" />

== See also ==
* [[Benzodiazepine]]

== References ==
{{Reflist}}

{{Anticonvulsants}}
{{GABAAR PAMs}}
{{Tricyclics}}

[[Category:Anticonvulsants]]
[[Category:Dibenzazepines]]
[[Category:Lactams]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Abandoned drugs]]

{{nervous-system-drug-stub}}